Sense https://validator.w3.org/feed/docs/rss2.html News Home Homepage banner test Sense Expands Leadership Team, Prepares for Launch of Veros™ COVID-19 Instrument-Free Molecular Test About Sense Support Patents Sense and R-Biopharm Nederland B.V. Agree to Distribute Rapid, Instrument-Free Molecular COVID-19 Test in the Netherlands, Belgium, and Luxembourg How to Clinical Sense and Bio Nuclear Diagnostics Agree to Distribute Rapid, Instrument-Free Molecular COVID-19 Test in Canada PHG Form Test Form Test Videos Careers Sense and Biotecom Agree to Distribute Rapid, Instrument-Free Molecular Test, Veros COVID-19 in Chile Sense and Abacus dx Agree to Distribute Rapid, Instrument-Free Molecular COVID-19 Test in Australia and New Zealand Sense Receives CE Marking for Veros™ COVID-19 Rapid, Instrument-Free Molecular Test Sense Announces Agreement to be Acquired by Sherlock Biosciences For Urgent Care Who Is Sense? How does Veros COVID-19 work? Why switch to Veros COVID-19? Is Veros COVID-19 available to purchase? How do I order? What comes with Veros COVID-19? Sense and Cruinn Diagnostics Sign Distribution Agreement to Market Veros COVID-19 in Ireland For Hospitals Sense Appoints Michael Jones as Chief Financial Officer Sense Announces New Executive Appointment as Company Prepares to Launch its Veros COVID-19 Test Overcoming the Limitations of Lab-Based PCR Sense and TECOmedical Sign Distribution Agreement for Germany, Austria, Switzerland Sense Announces Expansion of Manufacturing and Facilities to Support Launch of Rapid, Point-of-Care Molecular Diagnostic For Nursing Homes Sense Signs Distribution Agreement with Una Health for Point-of-Care PCR Quality Covid-19 Test Sense Announces Increase of Series B to $65 Million to Support Launch of Rapid, Point-of-Care Molecular Diagnostic Contact Us How It Works Video Sense Doubles Footprint with New Research and Development Facility Sense Appoints Timothy I. Still as President, CEO and Board Member Privacy Policy Sense Raises $50m Series B to Accelerate Launch of COVID-19 molecular test on its Veros™ Instrument-Free Product Platform Leadership